Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371200 · ClinicalTrials.gov registry record
Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
A clinical trial, sponsored by Brain Sentinel.
- Completed
- Registry status
- 13
- Enrollment target
NCT02371200: Completed study, sponsored by Brain Sentinel.
NCT02371200 is a clinical trial that has completed, run by Brain Sentinel. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02371200 has completed, sponsored by Brain Sentinel.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Prospective study of an electromyography (EMG) based seizure detection and warning system for detecting generalized tonic-clonic (GTC) seizures.
Primary Outcome
The primary outcome measure for this clinical trial will be the sensitivity of the Brain Sentinel™ Seizure Detection Systems ability to detect GTC seizure activity in comparison to a Neurologist independent review of vEEG collected in an epilepsy monitoring unit.
Interventions
- DEVICE Brain Sentinel Seizure Detection and Warning System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-02 |
What the finished NCT02371200 record still lists
NCT02371200 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Brain Sentinel Seizure Detection and Warning System is the first listed.
NCT02371200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02371200 about?
NCT02371200 is a clinical study titled "Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients". Prospective study of an electromyography (EMG) based seizure detection and warning system for detecting generalized tonic-clonic (GTC) seizures.
What is the current status of trial NCT02371200?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-04. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02371200?
The interventions under investigation include: Brain Sentinel Seizure Detection and Warning System (DEVICE).
Who is sponsoring clinical trial NCT02371200?
This trial is sponsored by Brain Sentinel, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia